ARISTEIA CAPITAL, L.L.C. - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.

Quarter-by-quarter ownership
ARISTEIA CAPITAL, L.L.C. ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q1 2022$1,887,000
+17.8%
49,200
-1.6%
0.03%
+21.4%
Q4 2021$1,602,000
-45.6%
50,000
-50.0%
0.03%
-49.1%
Q3 2021$2,947,000
-13.3%
100,0000.0%0.06%
-19.1%
Q2 2021$3,398,000
+4.6%
100,0000.0%0.07%
+7.9%
Q1 2021$3,250,000
-9.8%
100,0000.0%0.06%
-30.8%
Q4 2020$3,602,000
-13.2%
100,000
-5.7%
0.09%
-46.8%
Q3 2020$4,151,000
+6.8%
106,0000.0%0.17%
-14.1%
Q2 2020$3,888,000
+12.5%
106,000
-29.3%
0.20%
-31.8%
Q1 2020$3,456,000
-21.3%
150,0000.0%0.29%
+0.7%
Q4 2019$4,392,000
-63.5%
150,000
-66.7%
0.29%
-58.5%
Q3 2019$12,020,000
+4.5%
450,0000.0%0.70%
+31.1%
Q2 2019$11,502,000
-6.7%
450,000
-18.2%
0.53%
-20.7%
Q1 2019$12,331,000
+143.6%
550,000
+129.2%
0.67%
+100.0%
Q4 2018$5,062,000
+13.9%
240,0000.0%0.34%
+75.9%
Q3 2018$4,445,000
-17.0%
240,0000.0%0.19%
+2.7%
Q2 2018$5,354,000
-71.3%
240,000
-71.8%
0.19%
-74.9%
Q1 2018$18,683,000
-5.4%
850,0000.0%0.74%
-11.6%
Q4 2017$19,754,000
+1.2%
850,0000.0%0.84%
+10.0%
Q3 2017$19,516,000850,0000.76%
Other shareholders
VANECK VECTORS ETF TR shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders